Table VI.
Group I – NPDR | Group II – P/PDR | |||
---|---|---|---|---|
Oral treatment | Insulin treatment | Oral treatment | Insulin treatment | |
Sensitivity [%] | 47.2 | 64.1 | 75.6 | 82.9 |
Specificity [%] | 92.0 | 87.4 | 78.7 | 81.2 |
Group I – NPDR | Group II – P/PDR | |||
---|---|---|---|---|
Oral treatment | Insulin treatment | Oral treatment | Insulin treatment | |
Sensitivity [%] | 47.2 | 64.1 | 75.6 | 82.9 |
Specificity [%] | 92.0 | 87.4 | 78.7 | 81.2 |